对皮下高剂量生物制剂的临床开发和监管策略的行业观点
Gerard Bruin1, Ryan Nolan2, Shelley Amendola3
1Novartis, WSJ-386.10 North, CH-4002 Basel, Switzerland.
概括
开发高剂量皮下生物药物为患者提供像在家中使用一样的好处. 行业合作和创新是克服皮下药物输送和监管战略挑战的关键.
科学领域:
- 生物制药发展
- 药物输送系统
- 监管科学
背景情况:
- 通过皮下输送生物药物正在获得吸引力,以方便患者和减少医疗负担.
- 高剂量的生物制剂具有独特的配方和交付挑战.
- 行业对皮下注射越来越感兴趣,以改善患者的体验和坚持.
研究的目的:
- 对开发高剂量皮下生物产品的行业战略,挑战和最佳实践进行调查.
- 确定皮下药物开发中的关键驱动因素和障碍.
- 探索皮下生物制剂的发展机会.
主要方法:
- 由皮下药物开发和交付联盟的临床开发和监管战略子团队进行的跨公司调查.
- 探索当前行业对高剂量皮下配方开发的方法.
- 分析助力技术及其在克服技术障碍方面的作用.
主要成果:
- 业界认为高剂量皮下配方有利于以患者为中心的护理,减少访问,并使家庭管理成为可能.
- 关键的驱动因素包括改善剂量经验,增加守和生命周期管理.
- 像透增强器和可穿戴设备这样的支持技术正在被利用, 但用户接受和监管复杂性仍然存在.
结论:
- 通过建模和模拟,推进从静脉注射到皮下注射的桥梁策略是一个关键机会.
- 持续的合作和创新对于优化皮下高剂量生物发育至关重要.
- 适应不断变化的监管和以客户为中心的需求对于成功实施至关重要.
相关概念视频
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Biopharmaceutics and Pharmacokinetics: Overview
2.5K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
Routes of Drug Administration: Parenteral
2.1K
The administration of drugs via parenteral routes allows for direct drug introduction into the systemic circulation, resulting in high bioavailability because the medication bypasses the harsh conditions of the gastrointestinal tract and hepatic metabolism.
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
The intravenous route (IV) of drug administration can be further categorized into two types. The bolus injection administers the entire dose rapidly, while an intravenous infusion slowly delivers smaller doses steadily.
The IV route is often...
2.1K
Drug Delivery: Parenteral Route
831
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
831


